The generic market is expanding in Japan on back of government support and rising costs, and it is expected to post further growth in the years to come, says RNCOS.
(prHWY.com) February 20, 2012 - Noida, India -- In Japan, the government is taking various measures to increase the adoption of generics among people, mainly to reduce burgeoning healthcare costs and tackle rising cases of life-threatening diseases. According to a new research report by RNCOS, generics market in Japan has been strengthening in an effective manner for the past few years, and the generic drugs sector holds an immense growth potential due to increasing healthcare costs. It is expected that various developments and promising factors will boost the industry's revenue in near future, and the market will advance at a CAGR of around 9% during 2012-2014.
Research Analysis & Highlights
The report, "Japan Generics Market Analysis" is spread over 50 pages, and provides an in-depth research and rational analysis of the current status and expected position of the Japanese generics market. It facilitates forecasts on overall pharmaceutical industry size and generics market for the period 2012-2014. The research evaluates and analyzes the opportunities for generics companies in Japan in terms of patent expiries and therapeutic areas to be tapped. Regulatory environment's overview and recent industry developments have also been included in the report to provide a balanced outlook of the Japanese generic drugs market to clients.
Some of the key findings of the report are:
- The Japanese generic drugs market offers wide range of opportunities to both domestic and international market players.
- Dispensing pharmacies and DPC hospitals to play major role in the market growth.
- Neurological diseases and cancer are the focus area for the Japanese generic drugs manufacturers.
For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM371.htm
Some of our Related Reports are:
- Generic Drug Market in Canada (
http://www.rncos.com/Report/IM598.htm)
- Cancer Generics Market Analysis (
http://www.rncos.com/Report/IM353.htm)
- Booming Generics Drug Market in India (
http://www.rncos.com/Report/IM256.htm)
- UK Generics Market Analysis (
http://www.rncos.com/Report/IM313.htm)
Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
###